We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Lifotronic Technology Co., Ltd.

Lifotronic designs, develops, and manufactures medical devices, specializing in bedside treatment and diagnostic prod... read more Featured Products: More products

Download Mobile App





Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics

By LabMedica International staff writers
Posted on 06 Feb 2024

Lifotronic (Shenzhen, China) is demonstrating its latest medical innovations, including its CLIA, HPLC, CBC, and POCT solutions, at Medlab Middle East 2024. More...

Lifotronic is presenting a comprehensive range of solutions for large, medium, and small-sized laboratories to a global audience of experts and scholars at the show. Lifotronic’s eCL8000, dubbed the king of emergency, is one of the featured technology products at the exhibition. eCL 8000 is an 86 T/H fully automated analyzer based on the most advanced Electro-chemiluminescence Immunoassay (ECLIA). More than 90 parameters are available, covering thyroid, fertility, tumor, cardiac, inflammation, bone metabolism markers, etc. At Medlab Middle East 2024, Lifotronic is introducing its latest product, the eCL9000 electro-chemiluminescence analyzer which is designed especially for large labs, hospitals, and chain labs. It can perform 300 tests per hour at a constant speed, meeting the high demand of more than 100 samples per day. It also allows end users to easily conduct immunoassay tests. With a super long walkaway time of 5.5 hours, it frees up the operator’s time, improves work efficiency, and creates a more relaxed and flexible work environment.

Lifotronic is also showcasing its latest H100 high-pressure liquid chromatography analyzer which has a test speed of 96s/T. Convenient, fast, and accurate, it also has a one-click switch function for HbA1c and thalassemia modes. H100 can greatly improve the analysis process and achieve the ideal balance of quality, efficiency, and cost. In addition, Lifotronic is highlighting the AC310 and AC610 hematology analyzers which are widely recognized for their stable performance. These analyzers not only provide accurate and reliable clinical data for doctors but also offer patients a higher level of medical services. The AC630 hematology analyzer is the latest addition to the hematology analyzer series and its fully automated operation significantly improves the laboratory’s operational efficiency, as well as brings greater convenience to the operator. Lifotronic is also showcasing its complete solution for POCT using fluorescence immunochromatography and colloidal gold rapid detection. The POCT fluorescence immunochromatography analyzer offers several test parameters, is easy to carry, and enables fast detection. Its single-use cartridge design can satisfy the needs of primary healthcare facilities and small to medium-sized labs with low sample volumes.

Related Links:
Lifotronic


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
New
See-Saw Rocking Shaker
SH-200D-S-L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A blood-based test aims to address gaps in population-level early cancer detection (Photo courtesy of Harbinger Health)

Blood-Based MCED Test Enables Early-Stage Detection for Multiple Cancer Types

Around 84,000 new cancer cases in the United States each year are thought to arise from obesity, and over the past two decades, the rate of obesity-related cancers has climbed markedly. Thirteen malignancies... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.